Disseminated Intravascular Coagulation in Dogs and Cats: Signs, Diagnosis and Emergency Treatment

Disseminated Intravascular Coagulation in Dogs and Cats: Signs, Diagnosis and Emergency Treatment

By Dr Duncan Houston

A dog with sepsis begins oozing blood around an intravenous catheter. A cat with pancreatitis develops bruising, falling platelets and worsening kidney values. These may be visible signs of disseminated intravascular coagulation, but the abnormal clotting process may have started well before any bleeding was obvious.

Disseminated intravascular coagulation, usually shortened to DIC, is not one simple bleeding disorder. It is a severe complication of another disease that causes widespread activation of the clotting system throughout the body.

DIC can produce microscopic blood clots, impaired organ circulation and potentially fatal bleeding at the same time. It requires intensive hospital treatment, repeated laboratory testing and urgent control of the condition that triggered it.

Quick Answer

DIC is an acquired, life-threatening syndrome in which a serious underlying illness causes uncontrolled clotting throughout the circulation. Platelets and clotting proteins are consumed, blood vessels and organs can be damaged, and the patient may eventually begin bleeding.

Unexplained bruising, bleeding from catheter sites, blood in the urine or stool, breathing difficulty, severe weakness or collapse in an already sick dog or cat requires immediate emergency veterinary care. No single laboratory result confirms DIC, and treatment must be tailored to whether clotting, bleeding or both are occurring.

What Is Disseminated Intravascular Coagulation?

DIC is a secondary syndrome. It develops because another serious disease has triggered widespread activation of coagulation.

Under normal conditions, clot formation is limited to the site of an injured blood vessel. Once the vessel has been repaired, the clot is gradually removed.

In DIC, this control system begins to fail. Excessive thrombin is generated throughout the circulation, causing fibrin and platelets to form clots within small and sometimes larger blood vessels.

At the same time:

• Platelets are being consumed

• Clotting factors are being consumed

• Natural anticoagulants such as antithrombin may fall

• The blood vessel lining becomes injured

• Fibrinolysis, the system responsible for removing clots, becomes dysregulated

• Blood flow through organs may become impaired

As the process progresses, the patient may develop both thrombosis and bleeding.

Why Can DIC Cause Both Clotting and Bleeding?

The name sounds contradictory because owners are often told that their pet is forming too many clots while also being unable to clot normally.

Both statements can be true.

The clotting phase

Early in the process, systemic inflammation and blood vessel injury activate the clotting system. Numerous small clots may form within the circulation.

These microthrombi can restrict oxygen delivery to:

• The kidneys

• The lungs

• The liver

• The gastrointestinal tract

• The brain

• The heart

• The limbs

This phase may be predominantly hypercoagulable. Visible bleeding may be completely absent.

The consumption phase

As clot formation continues, platelets, fibrinogen and other clotting factors are used faster than the body can replace them.

The patient may then become hypocoagulable and develop:

• Petechiae

• Bruising

• Bleeding from mucous membranes

• Prolonged bleeding from catheter or injection sites

• Internal hemorrhage

DIC does not always move through these stages in a neat sequence. Thrombosis, factor consumption, abnormal fibrinolysis and bleeding may overlap.

Early DIC Versus Overt DIC

DIC exists along a continuum.

Early or non-overt DIC

In early disease:

• The patient has a serious predisposing condition

• Platelets may begin falling

• Antithrombin may decrease

• D-dimer may increase

• Fibrinogen may remain normal or increased

• PT and aPTT may still be normal or even shortened

• Visible bleeding may be absent

• Viscoelastic testing may show hypercoagulability

This stage is difficult to identify because the animal may appear to be clotting normally on routine screening tests.

A 2025 prospective study found that dogs with sepsis were hypercoagulable and had higher fibrinogen concentrations than dogs with non-infectious systemic inflammation. This demonstrates why a normal or high fibrinogen result cannot automatically exclude an early thromboinflammatory process.

Overt or decompensated DIC

As consumption progresses, findings may include:

• Marked thrombocytopenia

• Prolonged PT

• Prolonged aPTT

• Falling fibrinogen

• High D-dimer or fibrin degradation products

• Bleeding

• Anemia

• Shock

• Organ dysfunction

In practice, the mistake is waiting for dramatic hemorrhage before considering the diagnosis. By the time blood is visibly leaking from several sites, substantial coagulation and organ abnormalities may already be present.

Is DIC More Common in Dogs or Cats?

DIC is recognised in both dogs and cats, although the veterinary evidence is considerably stronger in dogs.

Cats can develop severe DIC, but their coagulation results may be less predictable and feline-specific diagnostic data remain limited.

In a retrospective study of 46 cats with DIC, visible hemorrhage was recorded in only seven cats. This means that most affected cats in that study did not present with obvious bleeding despite having laboratory or postmortem evidence of DIC.

What Causes DIC in Dogs and Cats?

DIC develops when an underlying disease produces sufficient inflammation, tissue injury, endothelial damage or release of procoagulant material to activate coagulation throughout the body.

Sepsis and overwhelming infection

Sepsis is one of the most important triggers.

Sources may include:

• Septic peritonitis

• Pyometra

• Severe pneumonia

• Infected wounds

• Bacterial urinary disease with systemic infection

• Gastrointestinal leakage

• Parvoviral enteritis

• Panleukopenia with secondary infection

• Severe tick-borne or vector-borne disease

Sepsis can produce a thromboinflammatory state involving endothelial injury, thrombin generation, reduced natural anticoagulant activity and impaired fibrinolysis.

Cancer

Neoplasia can activate coagulation through inflammation, abnormal blood vessels, tissue-factor expression, tumour necrosis or direct vascular injury.

Associated cancers include:

• Hemangiosarcoma

• Lymphoma

• Carcinoma

• Disseminated or metastatic neoplasia

• Other vascular or highly inflammatory tumours

Pancreatitis

Severe pancreatitis can trigger systemic inflammation, endothelial injury and marked coagulation abnormalities.

Dogs with acute pancreatitis may be hypercoagulable on thromboelastography, with increased fibrinogen and D-dimer and reduced antithrombin. Pancreatitis was also one of the most commonly identified underlying diseases in the retrospective feline DIC study.

Heatstroke

Heatstroke can cause direct endothelial injury, intestinal barrier damage, systemic inflammation, organ failure and consumptive coagulopathy.

DIC may develop during the initial crisis or become more apparent over the following hours.

Shock, trauma and tissue injury

Potential triggers include:

• Major trauma

• Severe shock

• Burns

• Extensive surgery

• Gastric dilatation-volvulus

• Tissue necrosis

• Prolonged poor circulation

Immune-mediated hemolytic anemia

Dogs with IMHA can develop severe hypercoagulability, thrombosis and laboratory changes consistent with DIC.

DIC and isolated thromboembolism are not identical, so each patient requires a complete coagulation assessment rather than assuming every clotting complication is automatically DIC.

Severe envenomation

Some snake venoms cause rapid consumption of coagulation factors, platelet dysfunction and fibrinolysis.

This may be described as venom-induced consumption coagulopathy rather than classic DIC because the mechanism can differ. Severe cases may nevertheless produce widespread clotting abnormalities, bleeding and organ injury.

Other associated conditions

Other reported associations include:

• Severe liver disease

• Acute hemolytic transfusion reactions

• Some systemic parasitic diseases

• Severe inflammatory disease

• Obstetric emergencies

• Extensive tissue destruction

In cats, neoplasia, pancreatitis and sepsis were the most common underlying conditions in the largest published retrospective feline DIC series.

Do Protein-Losing Kidney or Intestinal Diseases Cause DIC?

Protein-losing nephropathy and protein-losing enteropathy can cause antithrombin loss and increase the risk of thrombosis.

However, hypercoagulability or thrombosis is not automatically the same as DIC.

A dog with a protein-losing condition may develop:

• Reduced antithrombin

• Pulmonary thromboembolism

• Portal vein thrombosis

• Other systemic clots

DIC requires evidence of widespread coagulation activation and consumption in the setting of an appropriate underlying disease. Low antithrombin by itself does not confirm the diagnosis.

What Are the Signs of DIC?

The signs vary according to:

• The underlying disease

• Whether thrombosis or bleeding predominates

• Which organs are affected

• How quickly the syndrome is progressing

• Whether the patient is already in shock

Early signs may be subtle

Possible early findings include:

• Worsening lethargy

• Reduced appetite

• Fever or hypothermia

• Increasing heart rate

• Rapid breathing

• Weakness

• Poor peripheral circulation

• Falling urine production

• Unexpected deterioration despite treatment

• Progressive laboratory abnormalities without visible bleeding

Signs of abnormal bleeding

Bleeding signs may include:

• Petechiae, which look like tiny red or purple pinpoints

• Ecchymoses, which are larger areas of bruising

• Bleeding from the gums

• Nosebleeds

• Blood in the urine

• Blood in vomit

• Bright red or black stool

• Bleeding into the eyes

• Prolonged bleeding from venepuncture sites

• Oozing around intravenous catheters

• Bleeding from surgical incisions

• Blood within the chest or abdomen

Petechiae and bruising are important warning signs, but they are not specific to DIC. Severe thrombocytopenia, vasculitis and other clotting disorders can look similar.

Signs caused by thrombosis or organ injury

Microvascular or larger clots may cause:

• Sudden breathing difficulty

• Low blood oxygen

• Acute kidney injury

• Reduced urine production

• Neurological abnormalities

• Seizures

• Abdominal pain

• Intestinal injury

• Cold or painful limbs

• Abnormal heart rhythms

• Multiple organ dysfunction

The real concern is not only whether blood is visible. A patient may be losing organ perfusion from microscopic thrombosis without any external hemorrhage.

How Worried Should You Be?

Risk level	What it may look like	What it may mean	What to do
At risk	A patient with sepsis, heatstroke, severe pancreatitis, IMHA, trauma or cancer but no visible bleeding	Coagulation activation may be developing	Hospital monitoring and serial blood testing are appropriate
Suspected early DIC	Falling platelets, rising D-dimer, reduced antithrombin or abnormal viscoelastic results	Early or thrombosis-dominant DIC may be present	Intensive monitoring and treatment of the underlying disease are required
Overt DIC	Multiple coagulation abnormalities, bruising, catheter-site oozing, blood in urine or stool, organ dysfunction	Platelets and coagulation factors are being consumed	Emergency critical care and targeted blood-product support may be required
Critical DIC	Uncontrolled bleeding, respiratory distress, shock, collapse, seizures, anuria or multiple organ failure	Severe decompensation with high risk of death	Immediate intensive stabilisation and continuous reassessment are needed

Every animal with suspected DIC is already significantly ill. The severity framework describes how advanced the coagulation syndrome may be, not whether veterinary care is needed.

How Do Veterinarians Diagnose DIC?

There is no single definitive ante-mortem test for veterinary DIC.

Diagnosis is based on:

1. A disease known to trigger DIC

2. Evidence of systemic coagulation activation

3. Evidence of platelet or clotting-factor consumption

4. Evidence of fibrinolysis

5. Compatible clinical findings or organ dysfunction

6. Changes across serial samples

Veterinary scoring systems commonly combine several abnormalities rather than relying on one result. A large canine study assessed PT, aPTT, platelet count, fibrinogen, D-dimer and antithrombin and found that a composite score based on multiple abnormalities was more clinically useful than any individual value.

Complete Blood Count and Platelet Count

Platelet count

Thrombocytopenia is common because platelets are incorporated into systemic clots and consumed.

A falling platelet count may be more informative than a single mildly low value.

For example:

• A change from 300,000 to 150,000 platelets per microlitre may be clinically significant even though the second result is near some laboratory reference limits

• A stable platelet count of 120,000 may have a different meaning from a rapid fall to the same number

• Platelet clumping, particularly in cats, can create a falsely low automated result

A blood smear should therefore be reviewed to confirm thrombocytopenia and look for platelet clumps.

Red blood cells

Anemia may result from:

• Active bleeding

• Hemolysis

• Repeated blood sampling

• Dilution

• The underlying disease

Fragmented red blood cells called schistocytes may appear when red cells are damaged passing through fibrin strands or abnormal small blood vessels. They can support microangiopathic injury but are not specific enough to diagnose DIC alone.

Prothrombin Time and Activated Partial Thromboplastin Time

PT and aPTT assess different parts of secondary hemostasis.

In overt consumptive DIC, one or both may become prolonged because clotting factors have been depleted.

However:

• PT and aPTT may remain normal in early DIC

• They can occasionally be shortened during a hypercoagulable phase

• Liver disease, vitamin K deficiency and anticoagulant rodenticide poisoning can also prolong them

• A feline factor XII deficiency may markedly prolong aPTT without causing clinical bleeding

Normal clotting times do not reliably exclude early or thrombosis-dominant DIC. Prolonged times are also not specific enough to confirm it without the clinical context.

Fibrinogen

Fibrinogen is converted into fibrin during clot formation.

Low fibrinogen can support consumptive coagulopathy, particularly in a bleeding or hypocoagulable patient.

However, fibrinogen is also an acute-phase protein. Inflammatory diseases can increase fibrinogen production, particularly early in the process.

A normal or increased result therefore does not exclude DIC. What matters is:

• The underlying illness

• The direction of change

• The D-dimer

• Platelet trend

• Clotting times

• Viscoelastic findings

• Whether bleeding or thrombosis is occurring

Dogs with sepsis can be hyperfibrinogenemic and hypercoagulable rather than immediately hypofibrinogenemic.

D-Dimer and Fibrin Degradation Products

D-dimer is produced when cross-linked fibrin has been formed and then broken down.

An increased result means that clot formation and secondary fibrinolysis have occurred somewhere within the body.

It does not tell you:

• Where the clot formed

• Whether DIC is present

• Whether the patient is currently hypercoagulable

• Whether the clot is clinically important

• Whether bleeding, surgery or inflammation produced the increase

D-dimer can increase with:

• DIC

• Pulmonary or other thromboembolism

• Internal hemorrhage

• Surgery

• Trauma

• Neoplasia

• Liver disease

• Severe inflammation

It is a supporting test, not a stand-alone diagnosis.

Does a Negative D-Dimer Rule Out DIC?

Not reliably in every patient.

An early canine study comparing healthy dogs with dogs diagnosed with DIC found sensitivities between 85% and 100% for some D-dimer and fibrin degradation product assays. However, the study did not determine specificity in dogs with other systemic illnesses, which is the population in which the test is usually used clinically. Assay method and diagnostic threshold also changed test performance.

More recent work has shown that D-dimer does not reliably correlate with the overall hypercoagulable state identified by thromboelastography in critically ill dogs.

The test performs less reliably in cats. In one feline study, D-dimer testing had approximately 67% sensitivity and 56% specificity when sick cats with and without DIC were compared.

The practical interpretation is:

• A high D-dimer supports active fibrin turnover but does not confirm DIC

• A normal result may reduce suspicion in some dogs

• A normal result cannot universally exclude early, chronic or thrombosis-dominant DIC

• D-dimer is considerably less reliable as a feline rule-out test

• The exact assay and laboratory reference interval matter

Antithrombin

Antithrombin is one of the body’s most important natural anticoagulants.

Its activity may fall because of:

• Consumption during systemic coagulation

• Loss through the kidneys

• Loss through the gastrointestinal tract

• Reduced liver production

• Dilution

• Severe systemic illness

A low result can support DIC but is not specific.

Antithrombin also matters when considering heparin because heparin works largely by increasing antithrombin’s inhibition of activated coagulation factors. A patient with severely depleted antithrombin may respond less predictably to heparin treatment.

What Are TEG and ROTEM?

Thromboelastography and rotational thromboelastometry are viscoelastic tests that assess clot development and breakdown in whole blood.

They can provide information about:

• Time until clot formation begins

• Speed of clot development

• Overall clot strength

• Platelet and fibrinogen contribution

• Hypercoagulability

• Hypocoagulability

• Excessive fibrinolysis

This can be valuable because PT and aPTT only measure the time until initial fibrin formation in plasma. They do not show the strength or complete behaviour of the clot.

In a prospective study of 50 dogs diagnosed with DIC, hypercoagulability was the most common abnormal thromboelastographic pattern. Hypocoagulable dogs had a higher case fatality rate than hypercoagulable dogs in that population.

Limitations of viscoelastic testing

TEG and ROTEM do not replace clinical reasoning.

Results may be affected by:

• The machine and testing protocol

• Sample collection

• Time before analysis

• Activators used

• Platelet count

• Fibrinogen

• Hematocrit

• Species-specific reference intervals

• Recent transfusion or anticoagulant treatment

A normal viscoelastic result also does not prove that microscopic thrombosis is absent.

What Other Testing May Be Required?

Because DIC is secondary to another disease, the investigation must identify the trigger and assess organ damage.

Testing may include:

• Complete blood count

• Serum biochemistry

• Electrolytes

• Blood gas analysis

• Lactate

• Urinalysis

• Urine output measurement

• Blood cultures

• Infectious disease testing

• Abdominal ultrasound

• Thoracic radiographs

• Point-of-care ultrasound

• Echocardiography

• CT imaging

• Cytology or biopsy

• Snake-venom assessment in relevant regions

The patient may require repeated testing every few hours rather than one coagulation panel at admission. DIC is dynamic, and trends often reveal more than the initial sample.

What Else Can Look Like DIC?

Several disorders can cause bleeding, thrombosis or abnormal coagulation tests without representing DIC.

Anticoagulant rodenticide poisoning

This causes depletion of vitamin K-dependent clotting factors.

Typical findings include:

• Prolonged PT, often before aPTT

• Internal bleeding

• Pale gums

• Breathing difficulty

• Bruising or hematomas

Platelets are usually not consumed in the same pattern as DIC, and D-dimer may reflect secondary bleeding rather than systemic coagulation activation.

Severe liver disease

The liver produces most clotting proteins and natural anticoagulants.

Liver disease can cause:

• Prolonged PT and aPTT

• Low fibrinogen

• Thrombocytopenia

• High D-dimer from altered clearance

• Bleeding or thrombosis

Liver disease may mimic DIC, coexist with DIC or trigger it. This distinction can be particularly difficult in cats.

Immune-mediated thrombocytopenia

ITP can cause profound thrombocytopenia, petechiae, bruising and mucosal bleeding.

The clotting times are usually normal unless there is severe bleeding, concurrent disease or secondary consumption. A platelet count close to zero with otherwise relatively normal coagulation testing is more typical of ITP than classic overt DIC.

Vitamin K deficiency or biliary obstruction

Vitamin K deficiency affects factors II, VII, IX and X.

It may occur with:

• Rodenticide exposure

• Severe cholestasis

• Prolonged malabsorption

• Certain medications

Vitamin K can help these conditions but does not treat the uncontrolled systemic coagulation activation of DIC.

Congenital clotting-factor deficiency

Hemophilia and other inherited deficiencies usually produce a lifelong or recurrent bleeding tendency rather than sudden coagulation abnormalities caused by critical illness.

Acute traumatic or dilutional coagulopathy

Major trauma, massive hemorrhage, hypothermia, acidosis and large-volume fluid administration can produce coagulation failure.

Traumatic coagulopathy and DIC may overlap, but they are not automatically the same syndrome.

Localised thrombosis

Pulmonary thromboembolism, portal vein thrombosis or aortic thrombosis can occur without systemic consumption of platelets and coagulation proteins.

A high D-dimer and one confirmed clot do not automatically establish DIC.

How Is DIC Treated?

There is no single antidote for DIC.

Treatment must address four problems simultaneously:

1. Eliminate or control the trigger

2. Restore tissue perfusion and oxygen delivery

3. Manage clinically important bleeding or thrombosis

4. Support failing organs while coagulation recovers

Treating the Underlying Cause

This is the most important part of treatment.

Depending on the cause, treatment may include:

• Broad-spectrum antimicrobials and infection source control

• Surgery for septic peritonitis, pyometra or necrotic tissue

• Antivenom after snake envenomation

• Controlled cooling and organ support for heatstroke

• Treatment of pancreatitis

• Immunosuppressive treatment for IMHA when appropriate

• Management of shock

• Surgery or oncology treatment for neoplasia

• Treatment of severe parasitic or vector-borne disease

• Stopping a causative medication or transfusion

Blood products and anticoagulants cannot permanently control DIC while the triggering disease continues driving systemic coagulation.

Supporting Circulation and Oxygen Delivery

Supportive care may include:

• Oxygen

• Intravenous access

• Carefully titrated fluid resuscitation

• Vasopressors

• Analgesia

• Temperature control

• Glucose and electrolyte correction

• Mechanical ventilation

• Kidney support

• Nutritional support

• Acid-base correction

Fluid therapy must be individualised. Too little fluid can worsen tissue hypoperfusion, while excessive crystalloid administration can dilute platelets and clotting factors or contribute to pulmonary oedema.

The goal is adequate organ perfusion, not simply giving the largest possible fluid volume.

Are Blood Transfusions Used?

Blood products are selected according to the specific clinical deficit.

Packed red blood cells

Packed cells may be used when blood loss or hemolysis has caused clinically important anemia and inadequate oxygen delivery.

The aim is not necessarily to return the hematocrit to normal. It is to provide sufficient red blood cells to stabilise oxygen transport.

Whole blood

Whole blood may be useful when the patient requires both red blood cells and plasma components, particularly during major active hemorrhage.

Fresh frozen plasma

Plasma supplies coagulation factors and some natural anticoagulants.

It may be considered when:

• Clinically important bleeding is present

• Severe factor consumption is suspected

• An urgent invasive procedure is required

• Viscoelastic or conventional tests support factor deficiency

Plasma does not remove existing microthrombi or stop the underlying trigger. It also adds considerable volume, which may be dangerous in patients with cardiac, renal or pulmonary compromise.

Platelet products

Platelet-rich plasma, platelet concentrate or cryopreserved platelets may be considered when severe thrombocytopenia is contributing to life-threatening bleeding.

Availability is limited, and transfused platelets may be consumed rapidly while DIC remains active.

Cryoprecipitate

Cryoprecipitate provides concentrated fibrinogen, factor VIII, von Willebrand factor and factor XIII in a smaller volume than plasma.

It may be considered in selected patients with severe hypofibrinogenemia, particularly when volume administration must be limited.

Blood-product decisions should be driven by clinical bleeding, oxygen delivery, the procedure planned and the specific laboratory deficit rather than by the label of DIC alone.

Does Plasma Cure DIC?

No.

Plasma may temporarily replace depleted coagulation proteins, but it does not:

• Stop systemic coagulation activation

• Remove microthrombi

• Treat sepsis

• Remove a tumour

• Reverse heatstroke

• Correct endothelial injury

• Prevent all further factor consumption

In the retrospective feline DIC study, blood-product transfusion was not associated with improved survival. However, the study was retrospective, treatment was not standardised and the number of survivors was very small, so it cannot determine whether appropriately selected cats benefit from transfusion.

The practical point is that plasma is supportive treatment for a specific problem, not a cure for the syndrome.

Is Heparin Used for DIC?

Sometimes, but not in every patient.

Heparin enhances the action of antithrombin and can reduce further thrombin generation.

It may be considered when:

• The patient is predominantly hypercoagulable

• Thrombosis is documented or strongly suspected

• There is no uncontrolled bleeding

• Platelet numbers are adequate for the clinical situation

• Antithrombin activity is sufficient

• Appropriate monitoring is available

Heparin becomes much more difficult to justify when the patient has:

• Active major bleeding

• Profound thrombocytopenia

• Severe hypofibrinogenemia

• Markedly prolonged coagulation times

• An urgent surgical bleeding risk

Unfractionated heparin may be monitored using aPTT or anti-Xa activity. Low-molecular-weight heparin is generally monitored with anti-Xa testing when monitoring is performed.

Controlled veterinary evidence remains limited, and dose response can be highly variable in critically ill animals. Heparin should therefore never be treated as automatic therapy for every dog or cat labelled with DIC.

Are Aspirin or Clopidogrel Used?

Aspirin and clopidogrel affect platelet function rather than the full coagulation cascade.

They are useful for particular thrombotic conditions, but neither is a universal DIC treatment.

Administering an antiplatelet medication to a patient with severe thrombocytopenia or active bleeding can make hemorrhage worse. The choice between an anticoagulant, antiplatelet medication, blood product or no hemostatic drug depends on the individual coagulation phenotype.

Owners should never administer aspirin, clopidogrel or a human blood thinner without direct veterinary instructions.

Is Vitamin K Used?

Vitamin K does not treat DIC itself.

It may be appropriate when there is also:

• Anticoagulant rodenticide poisoning

• Cholestasis

• Vitamin K malabsorption

• A documented vitamin K-dependent factor deficiency

Giving vitamin K to every patient with prolonged clotting times can delay recognition of DIC, liver failure or another serious cause.

Are Steroids Used?

Steroids are not a direct treatment for DIC.

They may be required when the underlying trigger is an immune-mediated disease such as IMHA, but giving corticosteroids solely because coagulation results are abnormal is not appropriate.

Steroids can also increase infection risk, complicate glucose control and influence thrombosis risk.

What Monitoring Is Needed During Treatment?

DIC can change rapidly.

Hospital monitoring may include:

• Platelet count

• PCV or hematocrit

• PT and aPTT

• Fibrinogen

• D-dimer

• Antithrombin

• TEG or ROTEM

• Blood pressure

• Lactate

• Blood gases

• Electrolytes

• Kidney and liver values

• Urine output

• Oxygenation

• Neurological status

• Bleeding sites

• Limb temperature and pulses

• Evidence of new thrombosis

A single improved result does not prove the syndrome has resolved.

More reassuring trends include:

• Platelet count stabilising or rising

• PT and aPTT returning towards baseline

• Fibrinogen stabilising

• D-dimer decreasing

• Antithrombin recovering

• Lactate improving

• Urine production improving

• Bleeding stopping

• Organ function stabilising

What Is the Prognosis?

The prognosis is guarded and depends heavily on:

• The underlying cause

• Whether the cause can be reversed

• Whether DIC was recognised early

• Whether the patient is hypercoagulable or hypocoagulable

• Severity of bleeding

• Presence of thrombosis

• Number of organs affected

• Response to treatment

• Availability of intensive care and blood products

Prognosis in dogs

In a retrospective study of 804 dogs at risk of DIC, dogs meeting an institution-based definition of overt DIC had a mortality rate of 62.5%, compared with 12.9% among dogs that did not meet the overt DIC criteria. The diagnosis was associated with nearly five times the relative risk of nonsurvival.

In a separate study of 50 dogs with DIC assessed using thromboelastography, hypocoagulable dogs had a case fatality rate of 64%, compared with 32% among hypercoagulable dogs. These are study-specific figures, but they support the clinical importance of identifying the coagulation phenotype.

Prognosis in cats

In the retrospective study of 46 cats:

• Three cats survived

• Forty-three died or were euthanised

• Neoplasia, pancreatitis and sepsis were the most common underlying diseases

• Longer PT was associated with nonsurvival

This historical referral population contained many cats with severe or end-stage underlying diseases, and euthanasia was included in the outcome. The 7% survival figure should not be applied as a universal modern prediction for every cat diagnosed early with a potentially reversible trigger. It does show that feline DIC can be exceptionally serious.

More favourable findings

A better outlook is more likely when:

• The underlying cause is reversible

• Treatment begins before overt hemorrhage

• Blood pressure and perfusion respond

• Platelet counts stabilise

• Organ function remains preserved

• Bleeding can be controlled

• No major thromboembolic complication develops

• Coagulation trends improve during the first 24 to 48 hours

More concerning findings

The prognosis becomes poorer with:

• Refractory shock

• Progressive multiple organ dysfunction

• Severe hypocoagulability

• Uncontrolled bleeding

• Respiratory failure

• Acute kidney injury with falling urine production

• Progressive neurological abnormalities

• Severe thrombocytopenia

• Continuing deterioration despite treatment

• An untreatable or advanced underlying disease

No one coagulation value should be used alone to decide that treatment is futile.

When Is DIC an Emergency?

DIC is always a hospital-level emergency.

Seek immediate veterinary care if a sick dog or cat develops:

• Unexplained bruising

• Pinpoint red or purple spots on the gums or skin

• Bleeding from the mouth or nose

• Blood in the urine

• Black, tar-like stool

• Vomiting blood

• Bleeding from injection or catheter sites

• A swollen or painful abdomen

• Pale or grey gums

• Rapid or laboured breathing

• Sudden weakness

• Collapse

• Seizures

• Severe disorientation

• Cold or painful limbs

• Markedly reduced urine production

• Rapid deterioration over several hours

Do not wait for bleeding to stop by itself. DIC may be causing organ thrombosis and consumption even when the visible amount of blood appears small.

What Should You Do Right Now?

If your pet is at home

1. Call the nearest emergency veterinary hospital.

2. Explain the underlying disease and the bleeding or collapse you have observed.

3. Keep your pet calm and restrict movement.

4. Carry your pet when practical.

5. Apply gentle, continuous pressure to a small external bleeding site with clean gauze.

6. Bring all medication, toxin packaging and recent blood results.

7. Travel immediately.

Do not:

• Give aspirin

• Give ibuprofen or another NSAID

• Give heparin

• Give clopidogrel

• Give vitamin K unless already prescribed

• Give herbal clotting products

• Remove clots repeatedly from an oozing wound

• delay care while taking multiple photographs

• Assume a small external bleed means the internal problem is mild

If your pet is already hospitalised

Useful questions for the veterinary team include:

• What is the suspected trigger?

• Is my pet predominantly clotting, bleeding or showing both?

• Are platelets continuing to fall?

• Are PT and aPTT changing?

• What are the fibrinogen, D-dimer and antithrombin results?

• Has TEG or ROTEM been performed?

• Is there evidence of organ injury?

• What specific problem would a plasma or red cell transfusion treat?

• Is anticoagulation being considered, and what is the bleeding risk?

• What changes over the next 12 to 24 hours would improve or worsen the prognosis?

Common Mistakes Owners and Veterinary Teams Should Avoid

Waiting for obvious hemorrhage

DIC may begin as a thrombosis-dominant syndrome. Visible bleeding can be a late finding.

Diagnosing DIC from one high D-dimer

D-dimer confirms fibrin turnover, not DIC. It can increase with inflammation, cancer, trauma, surgery and internal bleeding.

Ruling DIC out because PT and aPTT are normal

Routine clotting times can remain normal during early or hypercoagulable disease.

Assuming low fibrinogen must always be present

Inflammation can increase fibrinogen production. A normal or high result does not exclude early DIC.

Treating a laboratory result rather than the patient

The decision to transfuse or anticoagulate should consider bleeding, thrombosis, perfusion, organ function and the complete coagulation profile.

Giving heparin automatically

Heparin may help a selected hypercoagulable patient but can worsen hemorrhage in a severely hypocoagulable patient.

Assuming plasma will stop the disease

Plasma may replace factors temporarily. It cannot control the underlying trigger.

Giving vitamin K for every prolonged PT

Vitamin K treats specific deficiencies. It does not switch off systemic coagulation activation.

Assuming thrombosis from protein loss automatically means DIC

Protein-losing kidney and intestinal disease can cause severe hypercoagulability without generalized consumption.

Stopping investigation after finding one cause of bleeding

A patient may have more than one problem, such as sepsis plus liver dysfunction, cancer plus internal hemorrhage or IMHA plus pulmonary thrombosis.

Can DIC Be Prevented?

DIC itself cannot always be prevented because it is a complication of severe illness.

Risk may be reduced through early recognition and aggressive treatment of the conditions that trigger it.

Helpful measures include:

• Treating sepsis promptly

• Performing early source control for pyometra or septic peritonitis

• Seeking immediate care for heatstroke

• Treating gastric dilatation-volvulus without delay

• Obtaining urgent antivenom assessment after snakebite

• Monitoring severe pancreatitis closely

• Providing appropriate thrombosis prevention for selected high-risk diseases

• Monitoring platelets and coagulation trends in critically ill patients

• Investigating unexpected bruising or catheter-site bleeding immediately

• Avoiding medications that interfere with clotting unless specifically prescribed

For hospitalised high-risk patients, prevention is less about one drug and more about recognising the coagulation shift before the patient reaches overt, hemorrhagic DIC.

Frequently Asked Questions

Can a dog or cat recover from DIC?

Yes. Recovery is possible when the underlying trigger can be controlled before irreversible organ damage develops. The prognosis remains guarded, particularly once shock, major hemorrhage or multiple organ failure is present.

Does a high D-dimer mean my pet has DIC?

No. A high D-dimer means that cross-linked fibrin has been formed and broken down. DIC, thrombosis, internal bleeding, surgery, inflammation, liver disease and cancer can all increase the result.

Can a normal D-dimer rule out DIC?

Not by itself. It may reduce suspicion in some dogs depending on the assay, but it cannot reliably exclude every early or chronic case. D-dimer is considerably less reliable as a rule-out test in cats.

Does fresh frozen plasma cure DIC?

No. Plasma may replace depleted coagulation proteins and help control bleeding, but it does not remove the trigger or prevent continued consumption.

Is DIC painful?

DIC itself can contribute to pain through tissue ischemia, thrombosis and organ injury. The underlying diseases, including pancreatitis, trauma, heatstroke, cancer and sepsis, may also be painful.

Final Takeaway

Disseminated intravascular coagulation is not simply a bleeding disorder.

It is a dynamic, life-threatening syndrome in which a severe underlying disease triggers widespread clot formation, consumption of platelets and coagulation proteins, abnormal fibrinolysis and possible organ failure.

The most important clinical lesson is that DIC may begin before visible bleeding develops. Falling platelets, increasing D-dimer, reduced antithrombin, changing clotting times and abnormal viscoelastic results in an at-risk patient should be assessed together and followed over time.

No single test confirms or excludes the diagnosis. Plasma, red cells and anticoagulants may each be appropriate in selected patients, but none should be used automatically without identifying whether bleeding, thrombosis or both are currently dominating.

Unexplained bruising, catheter-site bleeding, blood in the urine or stool, breathing difficulty, collapse or rapid deterioration in a critically ill dog or cat requires immediate emergency veterinary treatment.

---

If your dog or cat has unexpected bleeding, bruising or abnormal coagulation results during a serious illness, ASK A VET™ can help you organise the findings and understand which questions need to be discussed with the treating veterinary team urgently.